10.1
Introduction
Robot-assisted single-port (SP) surgery, which has been increasingly studied in the past decade, represents an opportunity to advance technology and improve patient outcomes. The da Vinci SP (Intuitive Surgical, Sunnyvale, California, United States) is a purpose-built system that received FDA approval in 2018 and follows years of innovation in institution-specific techniques in robotic-laparoendoscopic single-site surgery (R-LESS). The purpose-built SP da Vinci surgical system has enabled broader adoption of this technology among urologic surgeons. Early studies have supported acceptable perioperative outcomes with use of SP robotics. Patient outcomes with a novel surgical technique should be, at minimum, comparable to the standard of care to justify continued use. Here, we review the existing literature on perioperative outcomes and costs associated with SP urologic surgeries with a focus on comparison to MP surgeries.
10.2
Radical prostatectomy
SP-robot-assisted radical prostatectomy (RARP) is the most extensively studied of the SP urologic procedures, with atleast 23 case series and 9 comparative studies, altogether encompassing over 900 patients. Initial studies demonstrate feasibility and safety of single-site RARP and have since transitioned to assessing differences in patient outcomes based on limited follow-up data ( Table 10.1 ). Although nonstandard approaches to prostatectomy such as perineal and transvesical routes have been explored with SP robotics and shown to be feasible, extra- and transperitoneal RARP remain most popular and comprise the bulk of our discussion.
Year | Author | Title | n (R-SP RP) | Operative time (min) | EBL (mL) | # of nodes | LoS (days) | Clavien-Dindo complicatio n ≥2 rate | Pain scale (VAPS), OMEQ, or % pain-free at DC | + Margin rate | Erectile function | Continence rate (0–1 pads at 12 weeks) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R-LESS | 2009 | Kaouk et al. | Robotic single-port transumbilical surgery in humans: initial report | 1 | 300 | 250 | NR | 1.5 | 0 (0%) | 0 at 1 week | 0 (0%) | 1 (100%) at 3 weeks | 0 (0%) at 3 weeks |
2009 | Barrett et al. | Re: Initial complete laparoscopic single-site surgery robotic assisted radical prostatectomy (LESS-RARP) | 1 | 210 | 300 | NR | NR | 0 (0%) | NR | 0 (0%) | 1 (100%) | 1 (100%) | |
2010 | White et al. | Robotic laparoendoscopic single-site radical prostatectomy: technique and early outcomes | 20 | 187.6 | 128.8 | 4 | 2.5 | 3 (15%) | 1.6 VAPS, 22.3 OMEQ | 4/17 (23%) | NR | 9/11 (81%) at 16 weeks | |
2012 | White et al. | Robotic laparoendoscopic single site urological surgery: analysis of 50 consecutive cases | 20 | 189.5 | 142 | 4 | 2.7 | 3 (15%) | 1.4 | 4 (20%) | 1 SHIM>=21 at 3 months f/u; 2 at 1 year follow up | 18 (90%) at 4 months | |
2014 | Kaouk et al. | A novel robotic system for single-port urologic surgery: first clinical investigation | 11 | 239 | 350 | 4.5 | 5 | 3 (27.3%) | NR | 2 (18.2%) | 1/11 (9%) at 1 year | 6/11 (54.5%) at 1 month, 10/11 (91%) at 1 year | |
2016 | Kaouk et al. | Descriptive technique and initial results for robotic radical perineal prostatectomy. | 4 | 280 | 62.5 | NR | 1.4 | 0 (0%) | NR | 3 (75%) | NR | 4 (100%) at 6 months | |
2017 | Tugcu et al. | Single plus one port robotic radical prostatectomy (SPORP); Initial experience. | 8 | 143 | 45 | NR | NR | NR | NR | 0 (0%) | NR | 6 (75%) | |
2018 | Mattevi et al. | First case of robotic laparoendoscopic single-site radical prostatectomy with single-site VesPa platform. | 1 | 300 | 400 | NR | NR | 0 (0%) | NR | 0 (0%) | 0 (0%) | 0 (0%) at 12 weeks; 1 (100%) at 1 year | |
2018 | Tugcu et al. | Robotic perineal radical prostatectomy and robotic pelvic lymph node dissection via a perineal approach: the Tugcu Bakirkoy technique. | 7 | 184.1 | 64.2 | NR | 2.1 | NR | NR | 1 (14%) | NR | NR | |
2019 | Gaboardi et al. | Robotic laparoendoscopic single-site radical prostatectomy (R-LESS-RP) with daVinci Single-Site(R) platform. Concept and evolution of the technique following an IDEAL phase 1. | 12 | 256.2 | 165 | NR | 6.54 | 5 (41.7%) | NR | 1 (8.3) | 4/5 (80%) IIEF> 17 at mean 1 year f/u | 12 (100%) at mean 1 year f/u | |
Case series | 2019 | Chang et al. | Single-port transperitoneal robotic-assisted laparoscopic radical prostatectomy (spRALP): initial experience | 1 | 152 | 100 | NR | 4 | NR | NR | 0 (0%) | NR | NR |
2019 | Kaouk et al. | Single-port robot- assisted radical prostatectomy: first clinical experience using the SP surgical system | 2 | 140 | NR | NR | NR | NR | NR | NR | NR | NR | |
2019 | Kaouk et al. | Extraperitoneal single-port robot-assisted radical prostatectomy: initial experience and description of technique | 10 | 197.5 | 143 | 10.1 | 0 | 0 (0%) | NR | 5 (50%) | 3 (30%) at 12 weeks | 2 (20%) at 12 weeks; 5 (50%) at 90 days | |
2019 | Dobbs et al. | Single-port robot-assisted laparoscopic radical prostatectomy: initial experience and technique with the da Vinci SP platform | 10 | 234 | 65 | NR | 1 | 0 (0%) | NR | 2 (20%) | NR | NR | |
2019 | Ng et al. | Robot-assisted single-port radical prostatectomy: a phase 1 clinical study | 20 | 209 | 296 | 8.3 | 5 | 3 (15%) | 1.9 at 2 weeks | 11 (55%) | NR | NR | |
2019 | Steinberg et al. | Magnet-assisted robotic prostatectomy using the da Vinci SP robot: an initial case series | 15 | 224 | 198 | 10.25 | 1.25 | 1 (6.7%) | NR | 2 (13%) | NR | NR | |
2020 | Kaouk et al. | Robotic urologic surgical interventions performed with the single port dedicated platform: first clinical investigation. | 3 | 227 | 83 | 15 | 0.67 | 0 (0%) | NR | NR | NR | NR | |
2020 | Agarwal et al. | Initial experience with da Vinci single-port robot-assisted radical prostatectomies | 49 | 162 | 191 | 7.75 | 1.25 | 4 (8.2%) | NR | 13 (26.5%) | 10 (48%) at 12 weeks | 16/21 (76%) | |
2020 | Kim et al. | Single-port robot-assisted radical prostatectomy with the da Vinci SP system: a single surgeon’s experience | 20 | 245 | 200 | 19 | 7 | 0 (0%) | NR | 7 (35%) | 4/7 (57%) | 10/10 (100%) | |
2020 | Kaouk et al. | Single-port robotic urological surgery using purpose-built single-port surgical system: single-institutional experience with the first 100 cases | 60 | 104–281 | 50–200 | 5 | 0.14–2.26 | 6 (10%) | 41 (68.3%) opioid-free pain management | 18 (30%) | NR | 51.1% at 30 days | |
2020 | Wilson et al. | Outpatient extraperitoneal single-port robotic radical prostatectomy | 60 | 198 | 179 | NR | 0.18 | 7 (11.7%)≥3 | VAPS 2, 37% pain free at DC | 23% | 1/19 (5.26%) SHIM >19 at 90 days | 37 (76%) at 90 days | |
2020 | Aminsharifi et al. | Predictors associated with a prolonged hospital stay after single-port extraperitoneal robotic radical prostatectomy: a comparative analysis of outpatient versus inpatient care | 120 | 203.2 | 197.2 | NR | 0.19 | 7 (5.8%) | VAPS 2 at discharge | 29 (24.2%) | NR | 102 (85.0%) at 90 days | |
2020 | Covas Moschovas et al. | Early outcomes of single-port robot-assisted radical prostatectomy: lessons learned from the learning-curve experience | 50 | 118 | 50 | NR | 0.68 | 0 (0%) | 2 VAPS 8 h, 0 at 16 h | 7 (14%) | 70% at 6–8 weeks | 27 (54%) at 4 weeks | |
2021 | Kaouk et al. | Single-port transvesical robotic radical prostatectomy: initial | |||||||||||
Clinical experience and description of technique | 20 | 199 | 135 | NR | 0.18 | 1 (5%) | VAPs 2.5, 0 opioid use at DC | 3 (15%) | NR | 15 (75%) at Foley removal; 17 (85%) at 10 days | |||
Comparative | 2020 | Kaouk et al. | Extraperitoneal versus transperitoneal single port robotic radical prostatectomy: a comparative analysis of perioperative outcomes | 52 (SP) | 201 * | 145.7 | 5 * | 0.18 | 6 (11.5%) | NR | 14 (26.9%) | NR | 24 (60%) |
46 (MP) | 248.2 * | 117.6 | 12 * | 1.07 * * | 7 (15.2%) | NR | 19 (41.3%) | NR | 25 (62.5%) | ||||
2020 | Saidian et al. | Perioperative outcomes of single versus multi-port robotic assisted radical prostatectomy: a single institutional experience | 47 (SP) | 255.9 | 169.2 | 15.9 | 1.1 | 2 (4.3%) | NR | 10 (21.3%) | 3 (7.9%) at 12 weeks | 19 (63.3%) | |
48 (MP) | 274.7 | 157.7 | 15.1 | 1.4 | 3 (6.3%) | NR | 13 (27.1) | 3 (6.7%) at 12 weeks | 24/45 (53.3%) | ||||
2020 | Huang et al. | Comparison of perioperative and pathologic outcomes between single-port and standard robot-assisted radical prostatectomy: an analysis of a high-volume center and the pooled world experience | 26 (SP) | 180 | 100 * | 5 * | 1 | 3 (12%) | VAPS 2 | 6 (23.1%) | NR | NR | |
376 (MP) | 180 | 150 * , P =0.04 | 9 * , P =0.002 | 1 | 47 (13%) | VAPS 3 | 92 (24%) | NR | NR | ||||
2020 | Vigneswaran et al. | A comparison of perioperative outcomes between single-port and multiport robot-assisted laparoscopic prostatectomy | 50 (SP) | 260 | 100 | 12 * | 1 * | 7 (14%) | 29 OMEQ, 15 (30%) pain-free POD1 * | 20/48 (41.7%) | NR | 24 (86%) | |
113 (MP) | 280 | 100 | 14 * , P =0.012 | 2 * , P =0.002 | 17 (15%) | 28 OMEQ, 13 (12%) pain-free POD1, P =0.004 | 47/113 (41.6%) | NR | 84 (87%) | ||||
2020 | Lenfant et al. | Single-institution cost comparison: single-port versus multiport robotic prostatectomy | 78 (SP) | 198 * | NR | 5.18 | 0.41 * | NR | NR | 20 (26%) | NR | NR | |
97 (MP) | 223 * , P <0.001 | NR | 5.86 | 1.48 * , P <0.001 | NR | NR | 38 (39%) | NR | NR | ||||
2021 | Francavilla et al. | Radical prostatectomy technique in the robotic evolution: from da Vinci standard to single port—a single surgeon pathway | 40 (SP) | 238.5 * | 75 * | 12 | 1 * | 5 (12.5%)≥3 | NR | 15 (38.5%) | NR | 25/37 (67.6%) at 90 days | |
40 (MP) | 270.5 * , P <0.01 | 88 * , P <0.01 | 9 | 2 * , P <0.01 | 5 (12.5%)≥3 | NR | 21 (52.5%) | NR | 27/36 (75.0%) at 90 days | ||||
2021 | Abaza et al. | Single-port robotic surgery allows same-day discharge in majority of cases | 59 (SP) | 170 * | Not reported for each procedure. | ||||||||
1131 (MP) | 155.5 * , P <0.001 | Not reported for each procedure. | |||||||||||
2019 | Lenfant et al. | Pure single-site robot-assisted radical prostatectomy using single-port versus multiport robotic radical prostatectomy: a single-institution comparative study | 100 (SP) | 195 | 190 * | 5 | 0.18 * | 12 (12%) | 7.5 OMEQ * | 24 (24%) | 20% | 60 (69%) at 12 weeks; 34 (85%) at 1 year | |
110 (MP) | 190 | 200 * , P <0.0001 | 6 | 1.09 * , P <0.0001 | 6 (5.5%) | 15 OMEQ * , P <0.0001 | 37% | 25% | 60 (73%) at 12 weeks; 36 (88%) at 1 year | ||||
2021 | Covas Moschovas et al. | Comparing the approach to radical prostatectomy using the multiport da Vinci Xi and da Vinci SP robots: a propensity score analysis of perioperative outcomes | 71 (SP) | 114 * | 55 (78%) under 100 mL * | NR | NR | 0 (0%) | VAPS 2.5 at 18 h | 12 (17%) | 18% at 90 days | 68% at 90 days | |
71 (MP) | 103, P <0.001 | 36 (51%) * , P =0.002 | NR | NR | 0 (0%) | 2 | 11 (16%) | 28% | 56% |